收藏切换
Application analysis of clinical trial Data Monitoring Committee in the new pediatric drug research and development in China
收藏切换
Pengbo LI1, Yu ZHENG1, Jun LIU1, Zhong WANG1, Ya'nan YU1, *, Haixia DANG2, *
World Clinical Drug | 2025, 46(4) : 332 - 339
Less
收藏切换
World Clinical Drug | 2025, 46(4): 332-339
• Topic •
Application analysis of clinical trial Data Monitoring Committee in the new pediatric drug research and development in China
Full
Pengbo LI1, Yu ZHENG1, Jun LIU1, Zhong WANG1, Ya'nan YU1, *, Haixia DANG2, *
Affiliations
  • 1.Institute of Clinical Basic Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
  • 2.Research Center for the Development of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
Published: 2025-04-10 doi: 10.13683/j.wph.2025.04.003
Outline
收藏切换
Objective

To systematically analyze the application of Data Monitoring Committee (DMC) in clinical trials for new pediatric drug research and development in China, and the influence of some key trial characteristics on the application of DMC.

Methods

Based on the clinical trial records of pediatric new drug research and development published in the "Drug Clinical Trial Registration and Information Disclosure Platform" from January 1, 2013 to April 28, 2024, the trial characteristics and the application of DMC in different trial characteristics were sorted out and analyzed.

Results

A total of 612 trial records were included, of which 141 items (23.04%) were clinical trials using DMC. Since 2018, DMC applications have continued to grow. In terms of trial characteristics, the application rate of DMC in international trials was significantly higher than that in domestic trials (70.80% vs. 8.89%). The DMC application rate in multi-center trials was significantly higher than that in single-center trials (25.57% vs. 7.23%). The DMC application rate in the trials with sample size ≥100 and active termination trials were higher, which were 27.87% and 63.16%, respectively. The proportion of DMC application in phase III trial was high (35.85%). The DMC application rate in clinical trials of injectable dosage forms (26.64%) was significantly higher than that of oral dosage forms (22.62%), topical dosage forms (12.50%) and other dosage forms (15.79%).

Conclusion

At present, the application rate of DMC in clinical trials for pediatric drug research and development in China is generally low, and the key trial characteristics have an impact on the application of DMC. It is suggested to formulate corresponding DMC application standards according to the specific needs of the project and clinical trial characteristics to improve the quality and level of the trials.

Data Monitoring Committee  /  department of pediatrics  /  new drug research and development  /  clinical trial
李鹏博, 郑宇, 刘骏, 王忠, 于亚南, 党海霞. 临床试验数据监查委员会在我国儿科新药研发中的应用分析. 世界临床药物, 2025 , 46 (4) : 332 -339 . DOI: 10.13683/j.wph.2025.04.003
Pengbo LI, Yu ZHENG, Jun LIU, Zhong WANG, Ya'nan YU, Haixia DANG. Application analysis of clinical trial Data Monitoring Committee in the new pediatric drug research and development in China[J]. World Clinical Drug, 2025 , 46 (4) : 332 -339 . DOI: 10.13683/j.wph.2025.04.003
Year 2025 volume 46 Issue 4
50
11
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.04.003
  • Receive Date:2024-11-14
  • Online Date:2026-11-09
  • Published:2025-04-10
Article Data
Affiliations
History
  • Received:2024-11-14
Funding
Affiliations
    1.Institute of Clinical Basic Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
    2.Research Center for the Development of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.04.003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT